Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Recombinant human lecithin cholesterol acyltransferase

EU orphan designation number: EU/3/12/1051   
Active ingredient: Recombinant human lecithin cholesterol acyltransferase
Indication: Treatment of lecithin cholesterol acyltransferase deficiency
Sponsor: AstraZeneca AB
151 85 Södertälje, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/10/2012 Orphan designation EMA/OD/091/12 (2012)7228 of 10/10/2012
2/03/2016 Transfer of orphan designation EMA/OD/091/12/T/01 (2016)1376 of 29/02/2016
14/02/2019 Transfer of orphan designation EMA/OD/0000003174 (2019)1365 of 12/02/2019